A comprehensive structure-based alignment of prokaryotic and eukaryotic neurotransmitter/Na+ symporters (NSS) aids in the use of the LeuT structure to probe NSS structure and function

Molecular Pharmacology

Volumn 70, Issue 5, 2006, Pages 1630-1642

  Beuming, Thijs ^a   Shi, Lei ^a   Javitch, Jonathan A ^b   Weinstein, Harel ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEUCINE; NEUROTRANSMITTER; SODIUM SYMPORTER; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AQUIFEX AEOLICUS; ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; EUKARYOTIC CELL; NONHUMAN; PRIORITY JOURNAL; PROKARYOTE; PROTEIN STRUCTURE;

AMINO ACID SEQUENCE; AMINO ACID TRANSPORT SYSTEMS; BACTERIA; BINDING SITES; CONSERVED SEQUENCE; EUKARYOTIC CELLS; LEUCINE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PLASMA MEMBRANE NEUROTRANSMITTER TRANSPORT PROTEINS; PROKARYOTIC CELLS; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; SEQUENCE ALIGNMENT; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33751194447     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.106.026120     Document Type: Article

References (50)

1. Androutsellis-Theotokis A, Goldberg NR, Ueda K, Beppu T, Beckman ML, Das S, Javitch JA, and Rudnick G (2003) Characterization of a functional bacterial homologue of sodium-dependent neurotransmitter transporters. J Biol Chem 278: 12703-12709.
2. Ballesteros JA and Weinstein H (1995) Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in g protein-coupled receptors. Methods Neurosci 25:366-428.
3. Beitz E (2000) TEXshade: shading and labeling of multiple sequence alignments using LATEX2 epsilon. Bioinformatics 16:135-139.
4. Beuming T and Weinstein H (2004) A knowledge-based scale for the analysis and prediction of buried and exposed faces of transmembrane domain proteins. Bioinformatics 20:1822-1835.
5. Beuming T and Weinstein H (2005) Modeling membrane proteins based on lowresolution electron microscopy maps: a template for the TM domains of the oxalate transporter OxlT. Protein Eng Des Sel 18:119-125.
6. Brooks BR, Bruccoleri RE, Olafson BD, States DJ, Swaminathan S, and Karplus M (1983) CHARMM: a program for macromolecular energy, minimization, and dynamics calculations. J Comp Chem 4:187-217.
7. Chen N and Reith ME (2000) Structure and function of the dopamine transporter. Eur J Pharmacol 405:329-339.
8. Chen NH, Reith ME, and Quick MW (2004) Synaptic uptake and beyond: the sodium- and chloride-dependent neurotransmitter transporter family SLC6. Pflueg Arch Eur J Physiol 447:519-531.
9. Delano WL (2002) The PyMOL User's Manual. DeLano Scientific, San Carlos, CA.
10. Do CB, Mahabhashyam MS, Brudno M, and Batzoglou S (2005) ProbCons: probabilistic consistency-based multiple sequence alignment. Genome Res 15:330-340.
11. Fiser A and Sali A (2003) Modeller: generation and refinement of homology-based protein structure models. Methods Enzymol 374:461-491.
12. Goldberg NR, Beuming T, Soyer OS, Goldstein RA, Weinstein H, and Javitch JA (2003) Probing conformational changes in neurotransmitter transporters: a structural context. Eur J Pharmacol 479:3-12.
13. Gu H, Caplan MJ, and Rudnick G (1998) Cloned catecholamine transporters expressed in polarized epithelial cells: sorting, drug sensitivity, and ion-coupling stoichiometry. Adv Pharmacol 42:175-179.
14. Gu HH, Wu X, and Han DD (2006) Conserved serine residues in serotonin transporter contribute to high-affinity cocaine binding. Biochem Biophys Res Commun 343:1179-1185.
15. Hahn MK, Robertson D, and Blakely RD (2003) A mutation in the human norepinephrine transporter gene (SLC6A2) associated with orthostatic intolerance disrupts surface expression of mutant and wild-type transporters. J Neurosci 23: 4470-4478.
16. Hastrup H, Sen N, and Javitch JA (2003) The human dopamine transporter forms a tetramer in the plasma membrane: cross-linking of a cysteine in the fourth transmembrane segment is sensitive to cocaine analogs. J Biol Chem 278:45045-45048.
17. Henry LK, Defelice LJ, and Blakely RD (2006) Getting the message across: a recent transporter structure shows the way. Neuron 49:791-796.
18. Humphrey W, Dalke A, and Schulten K (1996) VMD: visual molecular dynamics. J Mol Graph 14:27-38, 33-38.
19. Jones DT (1999) Protein secondary structure prediction based on position-specific scoring matrices. J Mol Biol 292:195-202.
20. Jones DT, Taylor WR, and Thornton JM (1994) A model recognition approach to the prediction of all-helical membrane protein structure and topology. Biochemistry 33:3038-3049.
21. Koh IY, Eyrich VA, Marti-Renom MA, Przybylski D, Madhusudhan MS, Eswar N, Grana O, Pazos F, Valencia A, Sali A, et al. (2003) EVA: evaluation of protein structure prediction servers. Nucleic Acids Res 31:3311-3315.
22. Krause S and Schwarz W (2005) Identification and selective inhibition of the channel mode of the neuronal GABA transporter 1. Mol Pharmacol 68:1728-1735.
23. Krogh A, Larsson B, von Heijne G, and Sonnhammer EL (2001) Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol 305:567-580.
24. Krueger BK (1990) Kinetics and block of dopamine uptake in synaptosomes from rat caudate nucleus. J Neurochem 55:260-267.
25. Liakopoulos TD, Pasquier C, and Hamodrakas SJ (2001) A novel tool for the prediction of transmembrane protein topology based on a statistical analysis of the SwissProt database: the OrienTM algorithm. Protein Eng 14:387-390.
26. 2+ switch in the dopamine transporter: mutation of an intracellular tyrosine constitutively alters the conformational equilibrium of the transport cycle. Proc Natl Acad Sci USA 99:1683-1688.
27. 2+ switches in the gamma-aminobutyric acid (GABA) transporter-1. Differential effects on GABA uptake and currents. J Biol Chem 276:40476-40485.
28. Mitchell SM, Lee E, Garcia ML, and Stephan MM (2004) Structure and function of extracellular loop 4 of the serotonin transporter as revealed by cysteine-scanning mutagenesis. J Biol Chem 279:24089-24099.
29. Neubauer HA, Hansen CG, and Wiborg O (2006) Dissection of an allosteric mechanism on the serotonin transporter: a cross-species study. Mol Pharmacol 69:1242-1250.
30. Norregaard L and Gether U (2001) The monoamine neurotransmitter transporters: structure, conformational changes and molecular gating. Curr Opin Drug Discov Dev 4:591-601.
31. Norregaard L, Visiers I, Loland CJ, Ballesteros J, Weinstein H, and Gether U (2000) Structural probing of a microdomain in the dopamine transporter by engineering of artificial Zn2 binding sites. Biochemistry 39:15836-15846.
32. Notredame C, Higgins DG, and Heringa J (2000) T-Coffee: a novel method for fast and accurate multiple sequence alignment. J Mol Biol 302:205-217.
33. Pollastri G, Przybylski D, Rost B, and Baldi P (2002) Improving the prediction of protein secondary structure in three and eight classes using recurrent neural networks and profiles. Proteins 47:228-235.
34. Quick M, Yano H, Golberg NR, Duan L, Beuming T, Shi L, Weinstein H, and Javitch J (2006) State-dependent conformations of the translocation pathway in the tyrosine transporter Tyt 1. J Biol Chem 281:26444-26454.
35. Rost B (1999) Twilight zone of protein sequence alignments. Protein Eng 12:85-94.
36. Rost B, Yachdav G, and Liu J. The PredictProtein server. Nucleic Acids Res 32:W321-W326.
37. Roux MJ and Supplisson S (2000) Neuronal and glial glycine transporters have different stoichiometries. Neuron 25:373-383.
38. Rudnick G (1998) Ion-coupled neurotransmitter transport: thermodynamic vs. kinetic determinations of stoichiometry. Methods Enzymol 296:233-247.
39. Saier MH Jr (1999) A functional-phylogenetic system for the classification of transport proteins. J Cell Biochem 75 (Suppl 32-33):84-94.
40. Sen N, Shi L, Beuming T, Weinstein H, and Javitch JA (2005) A pincer-like configuration of TM2 in the human dopamine transporter is responsible for indirect effects on cocaine binding. Neuropharmacology 49:780-790.
41. Stajich JE, Block D, Boulez K, Brenner SE, Chervitz SA, Dagdigian C, Fuellen G, Gilbert JG, Korf I, Lapp H, et al. (2002) The Bioperl toolkit: Perl modules for the life sciences. Genome Res 12:1611-1618.
42. Tusnady GE, Dosztanyi Z, and Simon I (2005) PDB_TM: selection and membrane localization of transmembrane proteins in the protein data bank. Nucleic Acids Res 33 (Database Issue):D275-D278.
43. Tusnady GE and Simon I (2001) The HMMTOP transmembrane topology prediction server. Bioinformatics 17:849-850.
44. Vardy E, Arkin IT, Gottschalk KE, Kaback HR, and Schuldiner S (2004) Structural conservation in the major facilitator superfamily as revealed by comparative modeling. Protein Sci 13:1832-1840.
45. Volz TJ and Schenk JO (2005) A comprehensive atlas of the topography of functional groups of the dopamine transporter. Synapse 58:72-94.
46. von Heijne G (1992) Membrane protein structure prediction. Hydrophobicity analysis and the positive-inside rule. J Mol Biol 225:487-494.
47. Wu X and Gu HH (2003) Cocaine affinity decreased by mutations of aromatic residue phenylalanine 105 in the transmembrane domain 2 of dopamine transporter. Mol Pharmacol 63:653-658.
48. --dependent neurotransmitter transporters. Nature (Lond) 437:215-223.
49. Zhang YW and Rudnick G (2005) Cysteine-scanning mutagenesis of serotonin transporter intracellular loop 2 suggests an alpha-helical conformation. J Biol Chem 280:30807-30813.
50. Zomot E and Kanner BI (2003) The interaction of the gamma-aminobutyric acid transporter GAT-1 with the neurotransmitter is selectively impaired by sulfhydryl modification of a conformationally sensitive cysteine residue engineered into extracellular loop IV. J Biol Chem 278:42950-42958.